Marie-Noëlle Labour

Marie-Noëlle Labour

Auto-generated profile, based on publicly available information

Marie-Noëlle Labour

ICGM

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MCMichele A. Corrigan
Michele A. Corrigan
GJGillian P. Johnson
Gillian P. Johnson
ESElena Stavenschi
Elena Stavenschi
MRMathieu Riffault
Mathieu Riffault
MLMarie-Noelle Labour
Marie-Noelle Labour
DHDavid A. Hoey
David A. Hoey
Skeletal homeostasis requires the continued replenishment of the bone forming osteoblast from a mesenchymal stem cell (MSC) population, a process that has been shown to be mechanically regulated. However, the mechanisms by which a biophysical stimulus can induce a change in biochemical signaling, mechanotransduction, is poorly understood. As a precursor to loading-induced bone formation, deciphering the molecular mechanisms of MSC osteogenesis is a critical step in developing novel anabolic therapies. Therefore, in this study we characterize the expression of the mechanosensitive calcium channel Transient Receptor Potential subfamily V member 4 (TRPV4) in MSCs and demonstrate that TRPV4 localizes to areas of high strain, specifically the primary cilium. We demonstrate that TRPV4 is required for MSC mechanotransduction, mediating oscillatory fluid shear induced calcium signaling and early osteogenic gene expression. Furthermore, we demonstrate that TRPV4 can be activated pharmacologically eliciting a response that mirrors that seen with mechanical stimulation. Lastly, we show that TRPV4 localization to the primary cilium is functionally significant, with MSCs with defective primary cilia exhibiting an inhibited osteogenic response to TRPV4 activation. Collectively, this data demonstrates a novel mechanism of stem cell mechanotransduction, which can be targeted therapeutically, and further highlights the critical role of the primary cilium in MSC biology.

1 April 2017 in Journal of Biomechanics
Verified
Journal Article
Closed access
ESElena Stavenschi
Elena Stavenschi
MLMarie-Noelle Labour
Marie-Noelle Labour
DHDavid A. Hoey
David A. Hoey

1 July 2018 in Biomaterials
Verified
Journal Article
Closed access
NMN. Marinval
N. Marinval
MMM. Morenc
M. Morenc
MLM.N. Labour
M.N. Labour
ASA. Samotus
A. Samotus
AMA. Mzyk
A. Mzyk
HHHanna Hlawaty
Hanna Hlawaty

17 October 2016 in Scientific Reports
Verified
Journal Article
Open access
MLMarie-Noëlle Labour
Marie-Noëlle Labour
MRMathieu Riffault
Mathieu Riffault
SCSøren T. Christensen
Søren T. Christensen
DHDavid A. Hoey
David A. Hoey
The recruitment of mesenchymal stem cells (MSCs) is a crucial process in the development, maintenance and repair of tissues throughout the body. Transforming growth factor-β1 (TGFβ1) is a potent chemokine essential for the recruitment of MSCs in bone, coupling the remodelling cycle. The primary cilium is a sensory organelle with important roles in bone and has been associated with cell migration and more recently TGFβ signalling. Dysregulation of TGFβ signalling or cilia has been linked to a number of skeletal pathologies. Therefore, this study aimed to determine the role of the primary cilium in TGFβ1 signalling and associated migration in human MSCs. In this study we demonstrate that low levels of TGFβ1 induce the recruitment of MSCs, which relies on proper formation of the cilium. Furthermore, we demonstrate that receptors and downstream signalling components in canonical TGFβ signalling localize to the cilium and that TGFβ1 signalling is associated with activation of SMAD3 at the ciliary base. These findings demonstrate a novel role for the primary cilium in the regulation of TGFβ signalling and subsequent migration of MSCs, and highlight the cilium as a target to manipulate this key pathway and enhance MSC recruitment for the treatment of skeletal diseases.

1 February 2019 in Biomaterials
Verified
Journal Article
Closed access
BLBo Li
Bo Li
RARachida Aid-Launais
Rachida Aid-Launais
MLMarie-Noëlle Labour
Marie-Noëlle Labour
AZAlina Zenych
Alina Zenych
MJMaya Juenet
Maya Juenet
Cédric ChauvierreCédric Chauvierre
Cédric Chauvierre

2 September 2014 in European Cells and Materials
Verified
Journal Article
Closed access
MMM Mathieu
M Mathieu
SVS Vigier
S Vigier
MLM N Labour
M N Labour
CJC Jorgensen
C Jorgensen
EBE Belamie
E Belamie
Daniele NoelDaniele Noel
Daniele Noel
Because of poor self-healing ability, joint cartilage can undergo irreversible degradation in the course of various diseases or after injury. A promising approach for cartilage engineering consists of using of mesenchymal stem cells (MSC) and a differentiation factor combined with an injectable carrier biomaterial. We describe here a novel synthesis route for native collagen microspheres that does not involve the use of potentially toxic crosslinking agents. An emulsion was formed between a type I collagen solution and perfluorinated oil, stabilised by a biocompatible triblock perfluorinated copolymer surfactant. Spherical microparticles of fibrillar collagen were formed through a sol-gel transition induced by ammonia vapours. Electron microscopy observations showed that these self-cross-linked microspheres were constituted by a gel of striated collagen fibrils. Microspheres that were loaded with transforming growth factor beta (TGF-β)3 progressively released this differentiation factor over a four weeks period. Human MSC rapidly adhered to TGF-β3-loaded microspheres and, after 21 d of culture, exhibited typical chondrocyte morphology and produced an uncalcified matrix made of the predominant cartilage components, aggrecan and type II collagen, but devoid of the hypertrophic marker type X collagen. Subcutaneous co-injection of MSC and TGF-β3-loaded microspheres in mice consistently led to the formation of a cartilage-like tissue, which was however hypertrophic, calcified and vascularised. In conclusion, we developed cross-linker free collagen microspheres that allowed chondrogenic differentiation of MSC in vitro and in vivo.